XCOPRI
LIVE

Serial Number

88484180

Owner

SK Biopharmaceuticals Co., Ltd.

Attorney

Hun Joon Kim

First Use Date

May 11, 2020

Filing Date

Jun 21, 2019

Add to watchlist:

No watchlists yet
View on USPTO

XCOPRI Trademark

Serial Number: 88484180 • Registration: 6125911

XCOPRI is a trademark filed by SK Biopharmaceuticals Co., Ltd. on June 21, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SK Biopharmaceuticals Co., Ltd. (18 trademarks)

221, Pangyoyeok-ro
Gyeonggi-do 13494 , KR

Entity Type: 03

Trademark Details

Filing Date

June 21, 2019

Registration Date

August 11, 2020

First Use Anywhere

May 11, 2020

First Use in Commerce

May 11, 2020

Published for Opposition

February 11, 2020

Goods & Services

Medicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; pharmaceutical preparations for immunity adjustment; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 11, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 27, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 27, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 27, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
Aug 11, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 7, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 6, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 28, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 28, 2020 AITU
USE AMENDMENT FILED
May 11, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
May 11, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 7, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 2, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 23, 2019 CRFA
ASSIGNED TO LIE
Dec 11, 2019 ALIE
ASSIGNED TO LIE
Dec 6, 2019 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 27, 2019 ERSI
ASSIGNED TO EXAMINER
Oct 7, 2019 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 16, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 16, 2019 GNSL
SUSPENSION LETTER WRITTEN
Sep 16, 2019 CNSL
ASSIGNED TO EXAMINER
Sep 12, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 3, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2019 NWOS
NEW APPLICATION ENTERED
Jun 25, 2019 NWAP